Recommended not to take a vaccine if…’: Bharat Biotech releases fact sheet for Covaxin.
Key sentence:
- Bharat Biotech released a fact sheet on the procedure involved and also who should stop taking the vaccine.
- It also claimed that women who are pregnant and breastfeeding should stop taking Covaxin as well.
- The vaccine, therefore, has been generated by using an inactivated/killed virus together with the aforementioned chemicals.
India has started a major campaign towards the coronavirus disease (Covid-19) to vaccinate its population, which has taken more than 1.5 lakh lives in the nation.
Doctors were utilizing two vaccines – Covishield developed by the Serum Institute of India (SII) as well as Covaxin produced by Bharat Biotech – in the vaccination drive that started on January 16.
However, days after the vaccination campaign, Bharat Biotech released a fact sheet on the procedure involved and also who should stop taking the vaccine.
As per the fact paper by Bharat Biotech:
According to the fact paper published on the website of Bharat Biotech, if an individual has allergies, fever, or bleeding problems or is on a blood thinner, it is recommended not to have the vaccine.
It also claimed that women who are pregnant and breastfeeding should stop taking Covaxin as well. The company said that those who are immune-compromised or on medicines that damage the immune system and those who have acquired another Covid-19 vaccine should also not get the medication from Bharat Biotech.
CDSCO has authorized the restricted use of its vaccine:
So, who are all candidates for Covaxin shots, then? Bharat Biotech’s fact sheet states that CDSCO has approved the restricted use of all the vaccines in the clinical trial phase.
“Individuals who’ve been prioritized through the public health program of the ministry of health and family welfare will also be protected under this endeavour.
Advising the individuals about the deal for a vaccination with Covaxin will stay with the relevant government program officials. Those offering Covaxin at pre-specified booths will also have the choices to accept or reject the administering of the vaccine.
The company document described the elements in the Covaxin:
In addition, the company document identified the ingredients found in Covaxin. It comprises 64g of SARS-CoV-2 (Strain: NIV-2020-770) inactivated whole-virion antigen as well as other inactive components such as aluminium hydroxide gel (250 μg), 2-phenoxyethanol 2.5 mg, TLR 7/8 (imidazoquinolinone) agonist 15 μg, and saline phosphate buffer up to 0.5 ml.
“The vaccine, therefore, has been generated by using inactivated/killed virus together with the aforementioned chemicals,” Bharat Biotech says.
Covaxin is given as an injection into the upper arm’s deltoid muscle. Bharat Biotech also said that it is a two-dose series provided four weeks apart.
